Article: Sanofi-Aventis to acquire Indian vaccine company

French pharmaceutical company Sanofi-Aventis SA said Monday it has agreed to acquire a controlling stake in Indian vaccine maker Shantha Biotechnics Ltd. for an undisclosed amount.

The deal valued the Hyderabad-based Shantha at ??550 million ($783 million), Sanofi-Aventis said in a statement.

Under the terms of the agreement, the vaccines division Sanofi Pasteur will buy ShanH, a holding company that controls 80 percent of Shantha Biotechnics, from French biotechnology firm Merieux Alliance. The deal is expected to be completed by the end of the third quarter.

"Shantha provides Sanofi Pasteur with a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!